Community Engagement with the National Cancer Plan

Advocacy Organizations

Black in Cancer

"Black in Cancer’s awareness projects aim to provide culturally competent and accessible information about cancer to the community to educate and enhance participation in clinical trials." - Sigourney Bonner, Ph.D., Co-Founder and Director

Friends of Cancer Research

“This National Cancer Plan is a critical and actionable step towards improving patient outcomes.” – Ellen Sigal, Ph.D., Chair and Founder

TOUCH, The Black Breast Cancer Alliance (TOUCHBBCA)

"The time is now to advance science and improve prevention, detection, care, and survivorship for Black women at risk for and diagnosed with breast cancer. In alignment with the National Cancer Plan, we are excited to challenge the status quo by driving change with metrics-driven programming, bringing the patient voice to science, nurturing advocacy leadership, all while helping patients cope with this horrible disease." – Ricki Fairley, Chief Executive Officer, Co-Founder

Biotechnology Companies

Claradele Pharmaceuticals

“Claradele is committed to developing effective treatments and engaging every person so that all people with cancer can live a full and active life." – Rukiyah Van Dross-Anderson, Ph.D., Founder and Chief Executive Officer

NCI-Designated Cancer Centers

Dana-Farber Cancer Institute

“Our goals at the Centers for Early Detection and Interception are aligned with those of the National Cancer Plan, particularly to prevent cancer, detect cancers early, eliminate inequities, and deliver optimal care.” – Laurie H. Glimcher, M.D., President and Chief Executive Officer

Roswell Park Comprehensive Cancer Center

“The National Cancer Plan and our charters as NCI-Designated Cancer Centers challenge us to put our resources to work in new and creative ways to meet the particular needs of people in our communities. Roswell Park had an incredible opportunity to do just that through our Eddy program.” – Candace Johnson, Ph.D., President, Chief Executive Officer

Learn about how Roswell Park science advances the priorities of the plan in the Innovation Engine series of articles.

Sidney Kimmel Comprehensive Cancer Center

“The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins launched a new microsite dedicated to the National Cancer Plan. Connecting the plan’s goals with Kimmel research and patient care is a key feature of the site because we believe that NCI-Designated Cancer Centers like ours have an important role in the plan’s success.” – William Nelson, M.D., Ph.D., Director

University of Colorado Cancer Center

Learn about how the CU Cancer Center is helping in each of the eight goals in a series of articles posted April 28–August 4, 2023.

Government Agencies

Food and Drug Administration (FDA) Oncology Center of Excellence

“The National Cancer Plan represents a commitment to achieving a society where most cancers are prevented and where every person diagnosed with cancer lives a full and active life.” – Luckson Mathieu, M.D., Senior Clinical Reviewer, FDA Division of Oncology 2

Professional Societies

American Association for Cancer Research (AACR)

“I strongly agree with and support NCI’s position that ‘research is the backbone of the National Cancer Plan.’ Breakthroughs in cancer prevention, early detection, screening, diagnosis, and treatment are the result of decades of research and discoveries made by scientists in a wide array of disciplines.” – Margaret Foti, Ph.D., M.D. (hc), Chief Executive Officer

American Cancer Society (ACS)

“ACS is prepared to stand shoulder to shoulder with the NCI in accelerating the National Cancer Plan, leveraging our resources and sharing knowledge to accelerate progress and move us closer to the goal of ending cancer as we know it.” – Karen Knudsen, M.B.A., Ph.D., Chief Executive Officer

American Society for Radiation Oncology (ASTRO)

“Our strategic plan aligns with the National Cancer Plan goals, and we are committed to President Biden’s vision of reducing cancer mortality by 50% over the next 25 years.” – Jeff Michalski, M.D., M.B.A., FASTRO, Chair of ASTRO Board of Directors

American Society of Clinical Oncology (ASCO)

“This plan represents the exact kind of roadmap the nation needs. Decades of past federal research investment are already paying off with promising new methods of early detection and new treatments.” – Eric Winer, M.D., FASCO, President

“ASCO is proud to support the National Cancer Plan, which our organization believes is a roadmap to saving more lives in this country from cancer.” – Clifford Hudis, M.D., FACP, FASCO, Chief Executive Officer

Additional response from ASCO: Statement of support

Association of American Cancer Institutes (AACI)

“In the National Cancer Plan, Dr. Bertagnolli rallied traditional stakeholders of the cancer community to reach beyond existing partnerships to work toward our mutual goals. Now is the time for AACI cancer centers to wield their collective influence to educate members of Congress and demonstrate the value of cancer research firsthand.” – Jennifer Pegher, M.A., Executive Director

Additional responses from AACI: Statement of support, Commentary

Hematology/Oncology Pharmacy Association (HOPA)

“Tackling cancer is a complex task; however, by working together through interprofessional partnerships, we can advance cancer outcomes for all Americans." – Jolynn Sessions, Pharm.D., BCOP, CCP, FHOPA, President

National Comprehensive Cancer Network (NCCN)

“The National Cancer Plan emphasizes meaningful collaboration and knowledge sharing as cornerstones in the fight to end cancer as we know it.” – Robert Carlson, M.D., Chief Executive Officer

Oncology Nursing Society (ONS)

“Every day, the Oncology Nursing Society (ONS) works to improve quality of life and outcomes for people with cancer and their families by implementing the goals outlined in the National Cancer Plan.” – Brenda Nevidjon, M.S.N., R.N., FAAN, Chief Executive Officer

Health Care Facilities

Nationwide Children's Hospital

"Leaving this gap [data on cancers from diverse populations] unaddressed presents barriers to the National Cancer Plan goal of improving delivery of optimal care, as we determined in a retrospective study of Black patients with acute myeloid leukemia (AML)." - Elaine R. Mardis, Ph.D., Co-Executive Director, Steve and Cindy Rasmussen Institute for Genomic Medicine